病情分析:13价肺炎疫苗和23价肺炎疫苗都是预防肺炎的疫苗,但它们的组成和作用略有不同: 1.组成:13价肺炎疫苗包含13种肺炎球菌荚膜多糖结合蛋白,而23价肺炎疫苗包含23种肺炎球菌多糖抗原。 2.作用:PCV13对婴幼儿和儿童的肺炎、中耳炎和侵入性肺炎球菌病具有很好的保护作用。PPSV23主要适用于65岁及以上的老年人、...
In this work, for the 18-64-year-old group, PPSV23 and PCV13 serotypes accounted for 74.56% and 44.54% respectively of the cases in the studied period. On the other hand, for the 鈮 65-year-old group, these serotypes represented 72.30% and 41.42% respectively. The aim of this work...
权威发布!2015 ACIP建议:PCV13 与 PPSV23 两种肺炎疫苗的接种间隔现已上线。由免疫实践咨询委员会(ACIP,Advisory Committee on Immunization Practices)制定发布,囊括最新诊断标准、治疗方案及临床路径。现可咨询药智数据客服获取完整指南内容,助力临床决策制定。
//@火爸朱剑笛:PCV13和PPSV23算同类型的,所以只有一种特殊情况了→_→ http://t.cn/EIeuuhX //@儿科医生付亦男:咱把不能一起打的疫苗全列出来,我的记录是一次7针疫苗(有研究显示一次打完孩子受的苦更少[二哈])//@...
目前,美国批准使用两种肺炎球菌疫苗:13价肺炎球菌结合疫苗(PCV13)和23价肺炎球菌多糖疫苗(PPSV23).美国免疫实施顾问委员会(ACIP)建议,对既往未接种肺炎疫苗,≥65岁人群,以及由于潜在医学原因具有肺炎高危险性的≥2岁人群,接种1剂量PCV13后,可以接种1剂量PPSV23.两种疫苗接种的时间间隔,根据不同年龄,不同危险性人群...
肺炎球菌疫苗(PCV13或PPSV23) 百日咳疫苗(as part of Tdap或DTaP) 使用物制剂时禁忌接种的疫苗 活疫苗或减毒活疫苗(鼻内流感疫苗) 水痘带状疱疹疫苗 带状疱疹疫苗 黄热病疫苗 麻疹-流行性腮腺炎-风疹疫苗(MMR) 口服伤寒活疫苗 天花疫苗 结核卡介苗
Pneumococcal vaccine-naïve adults aged ≥ 65 years (n = 129) received a sequential administration with an interval of 0.5-y or 1.0-y or received a single administration of PPSV23 (single PPSV23). We evaluated the immunogenicity before and 1 month after each vaccination and at 0.5-y inte...
vaccine (PCV13), contains the seven serotypes in PCV7, five additional serotypes from PPSV23, and a new serotype not contained in PPSV23 or PCV7... CC Daniels,PD Rogers,CM Shelton - 《J Pediatr Pharmacol Ther》 被引量: 45发表: 2016年 Immunogenicity and safety of the 13-valent pneu...
Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Two pneumococcal vaccines are currently licensed for use in the United States: the 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals, Inc., a ...
National guidelines recommend sequential vaccination with PCV13 followed by PPSV23 in kidney transplant patients. However, there are currently no data on the serological response in kidney transplant recipients, who received a sequential vaccination with PCV13 and PPSV23. Methods: In the current ...